Join us for an engaging discussion on the evolving future of HIV prevention for women.

Her Choice. Her Future. will bring together leading experts in HIV prevention and women’s health to explore how far PrEP has come for women, what we have learned from the clinical and real-world experience with long-acting cabotegravir, and what the next generation of prevention may offer.

Through expert perspectives and an interactive faculty discussion, we’ll explore:

• Where we’ve been: The evolution of PrEP for women and the prevention needs that remain
• Where we are: Landmark efficacy and emerging real-world experience with long-acting cabotegravir
• Across her life: Considerations for conception, pregnancy, breastfeeding, and reproductive decision-making
• Where we’re going: Greater choice, longer protection, and the evolving future of PrEP for women

The program will conclude with a faculty discussion examining an important question:

What will the next era of HIV prevention for women require?

Monica Gandhi, MD, MPH

Professor of Medicine and Associate Chief for Education

University of California, San Francisco (UCSF)

Yolanda Lawson, MD, FACOG

Medical Director Abounding Prosperity, Associate Attending Baylor University Medical Center

Baylor University

Jeanne Marrazzo, MD, MPH, FACP, FIDSA

Chief Executive Officer

Infectious Diseases Society of America

Kimberly Y. Smith MD, MPH

Former Head of R&D 

ViiV Healthcare (retired)